Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.02M 964K 878K 1.65M 112M 1.65M 11.54M 4.45M 57.27M 4.41M 4.31M 185M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 9.99M 9.41M 8.57M 16.07M 1.1B 16.09M 113M 43.43M 559M 43.04M 42.09M 1.8B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.36%-0.11%-24.30%+4.09% 178B
-0.41%-2.19%-3.50%+14.03% 118B
+2.50%-2.99%+9.13%+71.14% 58.92B
-0.13%-1.21%-3.39%-31.82% 49.29B
-0.22%+0.78%+10.27%+47.46% 48.17B
-0.20%+5.30%+32.20%+0.10% 33.72B
+1.01%-1.93% - - 27.76B
-0.15%+1.85%+41.96%-3.34% 25.5B
+1.77%+9.57%+8.39%-13.10% 22.1B
Average +0.45%+1.07%+8.84%+11.07% 56.09B
Weighted average by Cap. +0.36%-0.14%-2.85%+12.98%

Financials

2007 2008
Net sales 986K 860K 810K 737K 1.38M 94.46M 1.38M 9.7M 3.74M 48.12M 3.7M 3.62M 155M 1.37M 1.2M 1.13M 1.03M 1.93M 132M 1.93M 13.51M 5.21M 67.05M 5.16M 5.05M 216M
Net income -10.38M -9.05M -8.52M -7.76M -14.55M -994M -14.57M -102M -39.33M -506M -38.98M -38.12M -1.63B -9.95M -8.68M -8.17M -7.44M -13.95M -953M -13.97M -97.86M -37.72M -486M -37.38M -36.55M -1.57B
Net Debt 4.09M 3.57M 3.36M 3.06M 5.74M 392M 5.75M 40.25M 15.51M 200M 15.37M 15.03M 645M 10.28M 8.97M 8.45M 7.69M 14.42M 985M 14.44M 101M 38.99M 502M 38.63M 37.78M 1.62B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!